|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.960 USD | +12.50% |
|
+5.32% | -69.08% |
| 08-03 | Plus Therapeutics, Inc. will Change its Name to Cerenome | CI |
| 08-03 | Plus Therapeutics, Inc. will Change its Ticker to CNSY from PSTV | CI |
| Market Cap | 24.23M 21.04M 19.61M 18.02M 34.08M 2.3B 34.45M 231M 90.4M 1.15B 90.99M 88.99M 3.82B | P/E 2026 * |
-1.01x | P/E 2027 * | -1.65x |
|---|---|---|---|---|---|
| Enterprise Value | 24.23M 21.04M 19.61M 18.02M 34.08M 2.3B 34.45M 231M 90.4M 1.15B 90.99M 88.99M 3.82B | EV / Sales 2026 * |
3.85x | EV / Sales 2027 * | 1.27x |
| Free-Float |
98.02% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Plus Therapeutics, Inc.
| 1 day | +12.50% | ||
| 1 week | +5.32% | ||
| Current month | +2.33% | ||
| 1 month | -2.22% | ||
| 3 months | -37.14% | ||
| 6 months | -34.57% | ||
| Current year | -69.08% |
| 1 week | 3.33 |  | 4.16 |
| 1 month | 3.33 | | 4.42 |
| Current year | 2.9 | | 15.32 |
| 1 year | 2.9 | | 23.42 |
| 3 years | 2.9 | | 80.25 |
| 5 years | 2.9 | | 870 |
| 10 years | 2.9 | | 429,377.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 64 | 01/04/2014 |
Andrew Sims
DFI | Director of Finance/CFO | 52 | 05/02/2020 |
Daniel Ortega
CTO | Chief Tech/Sci/R&D Officer | - | 20/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Hedrick
BRD | Director/Board Member | 64 | 30/09/2002 |
Richard Hawkins
CHM | Chairman | 77 | 24/01/2018 |
| Director/Board Member | 66 | 31/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Fiscal year | Director | 1,844 | 0.0269% | ||
| 01/07/26 | Fiscal year | Chief Financial Officer | 5,970 | 0.0870% | ||
| 01/07/26 | Fiscal year | Director | 1,844 | 0.0269% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.50% | +5.32% | -78.57% | -93.23% | 24.23M | |
| -0.68% | -0.54% | -2.73% | +13.55% | 48.22B | |
| +6.03% | +5.22% | +420.33% | +519.87% | 38.79B | |
| -2.21% | +7.03% | +25.08% | +5.51% | 38.41B | |
| +2.94% | -2.25% | +6.15% | +59.69% | 34.88B | |
| +1.98% | +3.97% | +13.89% | +40.90% | 29.19B | |
| +0.31% | +0.72% | +32.99% | +122.25% | 16B | |
| +0.47% | -3.87% | - | - | 16.05B | |
| +1.59% | +2.84% | +4.40% | +16.88% | 13.53B | |
| -0.98% | -12.98% | -4.82% | -38.09% | 12.22B | |
| Average | +2.29% | -1.11% | +46.30% | +71.93% | 24.73B | |
| Weighted average by Cap. | +1.37% | +0.21% | +79.05% | +112.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.3M 5.47M 5.1M 4.68M 8.85M 599M 8.95M 60.09M 23.49M 299M 23.64M 23.12M 992M | 19.14M 16.62M 15.5M 14.24M 26.92M 1.82B 27.22M 183M 71.42M 910M 71.88M 70.3M 3.02B |
| Net income | -26.8M -23.27M -21.7M -19.93M -37.7M -2.55B -38.11M -256M -100M -1.27B -101M -98.44M -4.22B | -18.45M -16.02M -14.94M -13.73M -25.96M -1.76B -26.24M -176M -68.86M -878M -69.3M -67.78M -2.91B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | US$3.960 | +12.50% | 137,612 |
| 03/08/26 | US$3.520 | -9.04% | 146,361 |
| 31/07/26 | US$3.870 | +6.03% | 96,526 |
| 30/07/26 | US$3.650 | +0.55% | 52,033 |
| 29/07/26 | US$3.630 | -3.46% | 94,049 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PSTV Stock
Select your edition
All financial news and data tailored to specific country editions
